New Study Examines GHK-Cu Mechanisms in Wound Healing

Researchers have published new findings on the copper peptide GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), identifying additional molecular pathways through which the compound may influence wound healing and tissue remodelling processes. The in-vitro study, published in a dermatology research journal, adds mechanistic detail to the existing preclinical evidence base for this naturally occurring tripeptide-copper complex.

GHK-Cu is a tripeptide that occurs naturally in human plasma, saliva, and urine, with concentrations declining with age. It has been studied since the 1970s for its role in tissue repair, and is commercially available as an ingredient in topical skincare products. Unlike many research peptides, GHK-Cu has a relatively well-characterised mechanism of action centred on copper ion delivery, gene expression modulation, and extracellular matrix remodelling.

The new study used human dermal fibroblast cultures to investigate GHK-Cu's effects on TGF-beta signalling pathways and matrix metalloproteinase (MMP) expression. Results showed that GHK-Cu treatment upregulated collagen type I and III synthesis at physiologically relevant concentrations while simultaneously modulating MMP-2 and MMP-9 activity in a dose-dependent manner. The authors propose that this dual action — promoting collagen synthesis while regulating collagen degradation — may explain the compound's observed effects on wound remodelling in previous animal studies.

The study also identified a previously unreported interaction between GHK-Cu and the Nrf2 antioxidant response pathway, suggesting an additional mechanism through which the peptide may protect healing tissue from oxidative damage. However, as with all in-vitro findings, the authors caution that cell culture results do not directly predict clinical efficacy and that controlled human studies are needed to validate these mechanistic observations.